Onconova Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
IMMUImmunomedics, Inc. -0.31%84.9911.0%$713.13m
MRNAModerna, Inc. 1.22%71.380.0%$674.47m
AMGNAmgen, Inc. 2.21%253.781.3%$673.72m
ILMNIllumina, Inc. 0.85%308.093.5%$631.89m
NVAXNovavax, Inc. 0.82%108.8496.5%$610.27m
GILDGilead Sciences, Inc. 1.51%63.041.0%$587.03m
REGNRegeneron Pharmaceuticals, Inc. -1.51%564.952.7%$432.37m
BIIBBiogen, Inc. 0.10%282.641.6%$351.16m
VRTXVertex Pharmaceuticals, Inc. 0.76%272.361.9%$348.64m
SRNESorrento Therapeutics, Inc. -5.47%10.971.5%$303.35m
ALXNAlexion Pharmaceuticals, Inc. 1.28%113.902.0%$283.52m
EXASEXACT Sciences Corp. 0.19%102.2020.7%$272.07m
SGENSeattle Genetics, Inc. 3.25%197.166.0%$234.83m
VXRTVaxart, Inc. -3.30%6.600.0%$191.16m
MNTAMomenta Pharmaceuticals, Inc. -0.01%52.493.0%$177.06m

Company Profile

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.